CROs or Pharma: The great innovation debate

At the Pharmaceutical Contract Management Group (PCMG) annual conference this month, representatives from CROs and pharma companies sat down to discuss which industry was leading in innovation. In one corner are CROs, whose proponents emphasized their recent progress in better forecasting trial budgets. In another, pharma bigwigs fired back at CROs, saying they aren't transparent enough, among other points. More from the intense discussion (check out some of the highlighted quotes), can be read at PharmExec. More

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.